Content
37%Reviews the quality of instructions and guidance provided to agents. Good implementation is clear, handles edge cases, and produces reliable results.
The skill is well-structured and names real domain tools, but it is far too verbose — teaching general pharmacology and regulatory knowledge Claude already has — and lacks executable examples, validation checkpoints, and any bundle/reference files for progressive disclosure.
Suggestions
Cut the background teaching (clinical trial phases, regulatory pathways, druggability tiers, success-rate benchmarks) and keep only GWAS-to-drug specifics Claude would not already know.
Add at least one executable tool-call example or concrete invocation per workflow step so the guidance is copy-paste ready rather than descriptive.
Insert explicit validation checkpoints between steps (e.g. confirm p-value filtering returned hits before druggability assessment) and move deep-dive material into reference files to enable proper progressive disclosure.
| Dimension | Reasoning | Score |
|---|---|---|
Conciseness | The ~570-line body explains large amounts of domain knowledge Claude already has (clinical trial phases, regulatory pathways, druggability tiers, success-rate benchmarks) and would benefit from drastic trimming. | 1 / 3 |
Actionability | Workflow steps name concrete tools (e.g. gwas_get_associations_for_trait, OpenTargets_get_target_tractability_by_ensemblID) and give a scoring formula, but provide no executable code or command examples showing how to call them. | 2 / 3 |
Workflow Clarity | The six-step pipeline is clearly sequenced with inputs/outputs per step, but there are no explicit validation checkpoints or feedback loops despite batch/target-ranking operations where errors should be caught early. | 2 / 3 |
Progressive Disclosure | Well-organized sections, but it is a monolithic SKILL.md with no bundle files and no offloaded references; deep-dive and reference material that should be one level deep is inline instead. | 2 / 3 |
Total | 7 / 12 Passed |